InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by He Wei-Wu, Chairman & CEO. Officer active across 1 company, notably CASI Pharmaceuticals, Inc.. Cumulatively, 3 filings have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €608k. History available since 18 August 2021. The latest transaction was disclosed on 13 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
He Wei-Wu is the Chairman and CEO of CASI Pharmaceuticals, Inc., a company focused on developing innovative treatments for serious diseases. Under his leadership, the company is committed to providing high-quality therapeutic solutions and improving patients' lives. He Wei-Wu plays a key role in the company's strategy and vision, overseeing operations and guiding the team towards achieving growth and innovation objectives.